Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?
Nov 4, 2015 ·
2m 53s
![Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/42e5e18ddb21d203ac8e661da38f5929.jpg)
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Drs. Leora Horn, Ben Solomon, & Jack West consider whether the data suggest that the better tested PD1 and PD-L1 inhibitors have differences in activity or tolerability or are essentially...
show more
Drs. Leora Horn, Ben Solomon, & Jack West consider whether the data suggest that the better tested PD1 and PD-L1 inhibitors have differences in activity or tolerability or are essentially interchangeable.
show less
Information
Author | cancerGRACE |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company